MREO
Mereo Biopharma Group Plc
Halal Rating :
Last Price
$2.86
Last updated:
Market Cap
-
7D Change
-14.37%
1 Year Change
-5.14%
Company Overview
Industries
Exchange
Next Earnings Date
Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to treat oncology and rare diseases. The company's primary focus is on developing treatments for various forms of cancer and rare bone diseases. They operate through research and development of novel pharmaceutical products.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Mereo Biopharma Group Plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.